Caricamento...
Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
Imatinib, a tyrosine kinase inhibitor, is well known to cause hypopigmentation because of its inhibitory effect on melanocytes. Herewith we report a case of chronic myeloid leukemia who developed extensive hyperpigmentation following imatinib therapy.
Salvato in:
| Pubblicato in: | Indian J Dermatol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Medknow Publications & Media Pvt Ltd
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601460/ https://ncbi.nlm.nih.gov/pubmed/26538739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5154.164447 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|